OrganoPlate® Graft
The OrganoPlate® Graft is the first in vitro cell culture platform that allows vascularization of 3D tissues like spheroids, organoids, and tumors in vitro.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Early drug discovery
Provides a unique intermediary between research projects and compound screening. The format of the plate provides the flexibility to support multiple cell types and configurations. Well designed for multi-modes of microscopy and the quantification of multiple reagents.
Review Date: 10 Feb 2020 | MIMETAS B.V.
The OrganoPlate® Graft is the first in vitro cell culture platform that allows vascularization of 3D tissues like spheroids, organoids, and tumors in vitro.
The OrganoPlate® Graft incorporates the unique technology developed by MIMETAS to grow functional microvessels in a chip to create a microvascular bed.
Tissue placed onto this bed is connected to the system of human blood vessels, achieving in vitro vascularization. This uniquely facilitates perfusion of the tissue and allows drug administration through the vasculature.